Parkinson´s Disease and Dementia in Parkinson's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Thirty-two participants will be selected between 50 and 80 years; diagnosed with idiopathic Parkinson's disease performed by specialized neurologists in extrapyramidal diseases according to the criterion of the Brains Bank of the UK Parkinson's Society; stages I to III of the Hoehn and Yahr scale; treated with levodopa and/or their synergists; do not present other neurological or orthopedic diseases diagnosed; do not present signs of dementia assessed using the Mini Mental State Examination with cutoff score according to educational level; with visual acuity and auditory normal or corrected; no prior experience with the Kinect system; have not participated in a rehabilitation program in the last two months and sign the Term of Consent of the study.
Exclusion criteria
Exclusion criteria: Patients will be excluded that during the period of the study present any clinical change that makes it impossible to perform physical exercises in standing position as cardiorespiratory; orthopedic or neurological disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PRIMARY OUTCOME EXPECTED: analysis of the change in the static postural balance and limits of stability modification verified through measure of center of pressure displacement (COP) in force plate (Balance Rehabilitation UnitTM) at an acquisition frequency of 100Hz. The mean and standart deviation of the displacement (range) of CoP trajectory will be recorded in medial-lateral (ML) and anterior-posterior (AP) directions and then will be analyzed in the three periods of evaluation of the study, both the control and experimental group, by using the statistical program SPSS version 20 (IBM Corp.). The static postural balance will be evaluated in 10 different situations: orthostatic position on firm ground with eyes open and eyes closed, orthostatic position on the foam with eyes closed; orthostatic position on firm ground with saccadic stimulation;orthostatic position on firm ground with optokinetic stimulation with horizontal direction from left to right;orthostatic position on firm ground with optokinetic stimulation with horizontal direction from right to left; orthostatic position on firm ground with vertical optokinetic stimulation with direction from the top down;orthostatic position on firm ground with optokinetic stimulation with vertical direction from the bottom up; orthostatic position on firm ground with optokinetic stimulation with horizontal direction associated with movements of head rotation;and orthostatic position on firm ground with vertical optokinetic stimulation direction associated with movements of flexion-extension of the head. Each position will be maintained for 60 seconds. | — |
Secondary
| Measure | Time frame |
|---|---|
| SECONDARY OUTCOME EXPECTED: Analysis to the improvement in postural control, functional mobility, cognition and quality of life using scales and / or questionnaires. Means and standard deviations of the scores obtained in the scale will be analyzed in the three periods of evaluation of the study, both the control and experimental group, by using the statistical program SPSS version 20 (IBM Corp.). The improvement in postural control will be assessed by Mini-Balance Evaluation Systems Test,scale consists of 14 items that assess the dynamic balance, session with each performance is evaluated normal (2) to severe (0), being that the smaller the final score, the worse the postural control; Improved functional mobility verified through time in seconds for the test to stand, walk and sit (Timed up and go test). The improved functional mobility and the risk of falls will be evaluated eight tasks involving gait in different sensorial contexts, including flat surface, changes in gait speed, horizontal and vertical head motions, go over and around obstacles, turning on his own body and up and down stairs through Dymanic Gait Index test. The improvement of cognition will be assessed by the Montreal Cognitive Scale which assesses different cognitive domains such as spatial and visuo executive functions, naming, memory, attention, language, abstraction, late evocation and orietation, with a total score of 30 points where higher scores than or equal to 26 indicate normal performance. The quality of life will be assessed by the Brazilian version of Parkinson's Disease Questionnaire consists of 39 items divided into 8 dimensions that include mobility, activities of daily life, emotional well-being, stigma, social support,cognition, communication and corporal discomfort, with scores ranging between 0 (no problem) to 100 (maximum problem, where a lower score indicates better perception by the individual for quality of life. | — |
Countries
Brazil
Contacts
Faculdade de Medicina da Universidade de São Paulo